鉴定 Boc2Lys 链接的乙酰丙酸及其类似物是否为高效的谷胱甘肽 S-转移酶降解剂

IF 3.5 3区 医学 Q2 CHEMISTRY, MEDICINAL ACS Medicinal Chemistry Letters Pub Date : 2024-10-14 DOI:10.1021/acsmedchemlett.4c0027410.1021/acsmedchemlett.4c00274
Hui Sun, Cong Wang, Xiaona Li, Zirui Lü, Kebin Li, Hengjie Hu, Ping Xu, Yu Xiao* and Yan Niu*, 
{"title":"鉴定 Boc2Lys 链接的乙酰丙酸及其类似物是否为高效的谷胱甘肽 S-转移酶降解剂","authors":"Hui Sun,&nbsp;Cong Wang,&nbsp;Xiaona Li,&nbsp;Zirui Lü,&nbsp;Kebin Li,&nbsp;Hengjie Hu,&nbsp;Ping Xu,&nbsp;Yu Xiao* and Yan Niu*,&nbsp;","doi":"10.1021/acsmedchemlett.4c0027410.1021/acsmedchemlett.4c00274","DOIUrl":null,"url":null,"abstract":"<p >Targeted protein degradation has been emerging as a promising strategy for drug design and a useful tool for the research of intracellular protein function by specifically downregulating the protein level via promoted degradation. Aside from proteolysis targeting chimeras (PROTAC) that utilize a specific E3 ligase ligand as a tag to recruit polyubiquitin onto the targeted protein and subsequently induce degradation, Boc<sub>3</sub>Arg was also reported an efficient tag to induce degradation through directly localizing the protein to the 20S proteasome. Based on the similarity of Boc<sub>2</sub>Lys and Boc<sub>3</sub>Arg, we identified that Boc<sub>2</sub>Lys also efficiently induced targeted protein degradation, taking glutathione S-transferase as an example. We found that Boc<sub>2</sub>Lys-linked ethacrynic acid was able to dose-dependently downregulate the target protein in a mechanism distinct to Boc<sub>3</sub>Arg.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"15 11","pages":"1852–1859 1852–1859"},"PeriodicalIF":3.5000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders\",\"authors\":\"Hui Sun,&nbsp;Cong Wang,&nbsp;Xiaona Li,&nbsp;Zirui Lü,&nbsp;Kebin Li,&nbsp;Hengjie Hu,&nbsp;Ping Xu,&nbsp;Yu Xiao* and Yan Niu*,&nbsp;\",\"doi\":\"10.1021/acsmedchemlett.4c0027410.1021/acsmedchemlett.4c00274\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Targeted protein degradation has been emerging as a promising strategy for drug design and a useful tool for the research of intracellular protein function by specifically downregulating the protein level via promoted degradation. Aside from proteolysis targeting chimeras (PROTAC) that utilize a specific E3 ligase ligand as a tag to recruit polyubiquitin onto the targeted protein and subsequently induce degradation, Boc<sub>3</sub>Arg was also reported an efficient tag to induce degradation through directly localizing the protein to the 20S proteasome. Based on the similarity of Boc<sub>2</sub>Lys and Boc<sub>3</sub>Arg, we identified that Boc<sub>2</sub>Lys also efficiently induced targeted protein degradation, taking glutathione S-transferase as an example. We found that Boc<sub>2</sub>Lys-linked ethacrynic acid was able to dose-dependently downregulate the target protein in a mechanism distinct to Boc<sub>3</sub>Arg.</p>\",\"PeriodicalId\":20,\"journal\":{\"name\":\"ACS Medicinal Chemistry Letters\",\"volume\":\"15 11\",\"pages\":\"1852–1859 1852–1859\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Medicinal Chemistry Letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00274\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsmedchemlett.4c00274","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

靶向蛋白质降解是一种很有前途的药物设计策略,也是通过促进降解特异性地降低蛋白质水平来研究细胞内蛋白质功能的有用工具。除了蛋白水解靶向嵌合体(PROTAC)利用特定的 E3 配体作为标签将多泛素募集到靶向蛋白上并随后诱导降解外,Boc3Arg 也被报道为一种有效的标签,通过直接将蛋白定位到 20S 蛋白酶体来诱导降解。基于 Boc2Lys 和 Boc3Arg 的相似性,我们以谷胱甘肽 S 转移酶为例,发现 Boc2Lys 也能有效诱导靶蛋白降解。我们发现,与 Boc2Lys 链接的乙基丙烯酸能够以一种不同于 Boc3Arg 的机制剂量依赖性地下调靶蛋白。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders

Targeted protein degradation has been emerging as a promising strategy for drug design and a useful tool for the research of intracellular protein function by specifically downregulating the protein level via promoted degradation. Aside from proteolysis targeting chimeras (PROTAC) that utilize a specific E3 ligase ligand as a tag to recruit polyubiquitin onto the targeted protein and subsequently induce degradation, Boc3Arg was also reported an efficient tag to induce degradation through directly localizing the protein to the 20S proteasome. Based on the similarity of Boc2Lys and Boc3Arg, we identified that Boc2Lys also efficiently induced targeted protein degradation, taking glutathione S-transferase as an example. We found that Boc2Lys-linked ethacrynic acid was able to dose-dependently downregulate the target protein in a mechanism distinct to Boc3Arg.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters CHEMISTRY, MEDICINAL-
CiteScore
7.30
自引率
2.40%
发文量
328
审稿时长
1 months
期刊介绍: ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to: Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics) Biological characterization of new molecular entities in the context of drug discovery Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc. Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic Mechanistic drug metabolism and regulation of metabolic enzyme gene expression Chemistry patents relevant to the medicinal chemistry field.
期刊最新文献
Issue Editorial Masthead Issue Publication Information In This Issue, Volume 15, Issue 11 Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors Design, Synthesis, and Biological Evaluation of 3-Amino-pyrazine-2-carboxamide Derivatives as Novel FGFR Inhibitors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1